Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
Genmab
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
University of Chicago
National Cancer Institute (NCI)
Universität des Saarlandes
Arcus Biosciences, Inc.
AstraZeneca
Washington University School of Medicine
Institut Claudius Regaud
Pfizer